Eric A. Weaver, Ph.D. - Publications

2002 Texas A & M University, College Station, TX, United States 
Genetics, Veterinary Science Biology

36 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Crosby CM, Weaver EA, Khare R, Barry MA. A Novel Codon-optimized SIV Gag-pol Immunogen for Gene-based Vaccination. Virology Reports. 5: 47-55. PMID 26550557 DOI: 10.1016/j.virep.2015.03.002  0.56
2015 Webby RJ, Weaver EA. Centralized Consensus Hemagglutinin Genes Induce Protective Immunity against H1, H3 and H5 Influenza Viruses. Plos One. 10: e0140702. PMID 26469190 DOI: 10.1371/journal.pone.0140702  0.56
2015 Weaver EA, Camacho ZT, Hillestad ML, Crosby CM, Turner MA, Guenzel AJ, Fadel HJ, Mercier GT, Barry MA. Mucosal vaccination by adenoviruses displaying reovirus sigma 1. Virology. 482: 60-6. PMID 25827529 DOI: 10.1016/j.virol.2015.02.050  0.56
2014 Camacho ZT, Turner MA, Barry MA, Weaver EA. CD46-mediated transduction of a species D adenovirus vaccine improves mucosal vaccine efficacy. Human Gene Therapy. 25: 364-74. PMID 24635714 DOI: 10.1089/hum.2013.215  0.56
2013 Weaver EA, Barry MA. Low seroprevalent species D adenovirus vectors as influenza vaccines. Plos One. 8: e73313. PMID 23991187 DOI: 10.1371/journal.pone.0073313  0.56
2013 Weaver EA, Nehete PN, Nehete BP, Yang G, Buchl SJ, Hanley PW, Palmer D, Montefiori DC, Ferrari G, Ng P, Sastry KJ, Barry MA. Comparison of systemic and mucosal immunization with helper-dependent adenoviruses for vaccination against mucosal challenge with SHIV. Plos One. 8: e67574. PMID 23844034 DOI: 10.1371/journal.pone.0067574  0.56
2012 Cummins NW, Weaver EA, May SM, Croatt AJ, Foreman O, Kennedy RB, Poland GA, Barry MA, Nath KA, Badley AD. Heme oxygenase-1 regulates the immune response to influenza virus infection and vaccination in aged mice. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 26: 2911-8. PMID 22490782 DOI: 10.1096/fj.11-190017  0.56
2012 Weaver EA, Mercier GT, Gottschalk S, Barry MA. T-cell-biased immune responses generated by a mucosally targeted adenovirus-σ1 vaccine Mucosal Immunology. 5: 311-319. PMID 22377931 DOI: 10.1038/mi.2012.11  0.56
2012 Barry MA, May S, Weaver EA. Imaging luciferase-expressing viruses. Methods in Molecular Biology (Clifton, N.J.). 797: 79-87. PMID 21948470 DOI: 10.1007/978-1-61779-340-0_6  0.56
2012 Barry MA, Weaver EA, Chen CY. Mining the adenovirus "virome" for systemic oncolytics. Current Pharmaceutical Biotechnology. 13: 1804-8. PMID 21740366 DOI: 10.2174/138920112800958823  0.56
2011 Chen CY, Senac JS, Weaver EA, May SM, Jelinek DF, Greipp P, Witzig T, Barry MA. Species D adenoviruses as oncolytics against B-cell cancers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 6712-22. PMID 21890454 DOI: 10.1158/1078-0432.CCR-11-0968  0.56
2011 Chen CY, Weaver EA, Khare R, May SM, Barry MA. Mining the adenovirus virome for oncolytics against multiple solid tumor types. Cancer Gene Therapy. 18: 744-50. PMID 21886190 DOI: 10.1038/cgt.2011.47  0.56
2011 Weaver EA, Chen CY, May SM, Barry ME, Barry MA. Comparison of adenoviruses as oncolytics and cancer vaccines in an immunocompetent B cell lymphoma model. Human Gene Therapy. 22: 1095-100. PMID 21770794 DOI: 10.1089/hum.2011.071  0.56
2011 Khare R, May SM, Vetrini F, Weaver EA, Palmer D, Rosewell A, Grove N, Ng P, Barry MA. Generation of a Kupffer cell-evading adenovirus for systemic and liver-directed gene transfer. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 1254-62. PMID 21505422 DOI: 10.1038/mt.2011.71  0.56
2011 Weaver EA, Rubrum AM, Webby RJ, Barry MA. Protection against divergent influenza H1N1 virus by a centralized influenza hemagglutinin. Plos One. 6: e18314. PMID 21464940 DOI: 10.1371/journal.pone.0018314  0.56
2011 Khare R, Chen CY, Weaver EA, Barry MA. Advances and future challenges in adenoviral vector pharmacology and targeting. Current Gene Therapy. 11: 241-58. PMID 21453281 DOI: 10.2174/156652311796150363  0.56
2011 Hofherr SE, Adams KE, Chen CY, May S, Weaver EA, Barry MA. Real-time dynamic imaging of virus distribution in vivo. Plos One. 6: e17076. PMID 21347236 DOI: 10.1371/journal.pone.0017076  0.56
2011 Weaver EA, Hillestad ML, Khare R, Palmer D, Ng P, Barry MA. Characterization of species C human adenovirus serotype 6 (Ad6). Virology. 412: 19-27. PMID 21251688 DOI: 10.1016/j.virol.2010.10.041  0.56
2010 Weaver EA. A detailed phylogenetic analysis of FIV in the United States. Plos One. 5: e12004. PMID 20711253 DOI: 10.1371/journal.pone.0012004  0.56
2010 Barry MA, Weaver EA, Hofherr SE. Rescue, amplification, purification, and PEGylation of replication defective first-generation adenoviral vectors. Methods in Molecular Biology (Clifton, N.J.). 651: 227-39. PMID 20686969 DOI: 10.1007/978-1-60761-786-0_13  0.56
2010 Weaver EA, Camacho ZT, Gao F. Similar T-cell immune responses induced by group M consensus Env immunogens with wild-type or minimum consensus variable regions Aids Research and Human Retroviruses. 26: 577-584. PMID 20438382 DOI: 10.1089/aid.2009.0258  0.56
2009 Weaver EA, Nehete PN, Nehete BP, Buchl SJ, Palmer D, Montefiori DC, Ng P, Sastry KJ, Barry MA. Protection against Mucosal SHIV Challenge by Peptide and Helper-Dependent Adenovirus Vaccines. Viruses. 1: 920. PMID 20107521 DOI: 10.3390/v1030920  0.56
2009 Weaver EA, Nehete PN, Buchl SS, Senac JS, Palmer D, Ng P, Sastry KJ, Barry MA. Comparison of replication-competent, first generation, and helper-dependent adenoviral vaccines. Plos One. 4: e5059. PMID 19333387 DOI: 10.1371/journal.pone.0005059  0.56
2008 Weaver EA, Barry MA. Effects of shielding adenoviral vectors with polyethylene glycol on vector-specific and vaccine-mediated immune responses. Human Gene Therapy. 19: 1369-82. PMID 18778197 DOI: 10.1089/hgt.2008.091  0.56
2008 Hofherr SE, Shashkova EV, Weaver EA, Khare R, Barry MA. Modification of adenoviral vectors with polyethylene glycol modulates in vivo tissue tropism and gene expression. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 1276-82. PMID 18461056 DOI: 10.1038/mt.2008.86  0.56
2007 Mercier GT, Nehete PN, Passeri MF, Nehete BN, Weaver EA, Templeton NS, Schluns K, Buchl SS, Sastry KJ, Barry MA. Oral immunization of rhesus macaques with adenoviral HIV vaccines using enteric-coated capsules. Vaccine. 25: 8687-701. PMID 18063450 DOI: 10.1016/j.vaccine.2007.10.030  0.56
2006 Liao HX, Sutherland LL, Xia SM, Brock ME, Scearce RM, Vanleeuwen S, Alam SM, McAdams M, Weaver EA, Camacho Z, Ma BJ, Li Y, Decker JM, Nabel GJ, Montefiori DC, et al. A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses. Virology. 353: 268-82. PMID 17039602 DOI: 10.1016/j.virol.2006.04.043  0.56
2006 Weaver EA, Lu Z, Camacho ZT, Moukdar F, Liao HX, Ma BJ, Muldoon M, Theiler J, Nabel GJ, Letvin NL, Korber BT, Hahn BH, Haynes BF, Gao F. Cross-subtype T-cell immune responses induced by a human immunodeficiency virus type 1 group m consensus env immunogen. Journal of Virology. 80: 6745-56. PMID 16809280 DOI: 10.1128/JVI.02484-05  0.56
2006 Kothe DL, Li Y, Decker JM, Bibollet-Ruche F, Zammit KP, Salazar MG, Chen Y, Weng Z, Weaver EA, Gao F, Haynes BF, Shaw GM, Korber BT, Hahn BH. Ancestral and consensus envelope immunogens for HIV-1 subtype C. Virology. 352: 438-49. PMID 16780913 DOI: 10.1016/j.virol.2006.05.011  0.56
2005 Li Z, Phadke A, Weaver EA, Ball JM, Collisson EW. Feline CD8+ cells induced with FIV infected, irradiated T cells produce multiple anti-FIV factors. Developmental and Comparative Immunology. 29: 809-24. PMID 15936436 DOI: 10.1016/j.dci.2005.01.003  0.56
2005 Gao F, Weaver EA, Lu Z, Li Y, Liao HX, Ma B, Alam SM, Scearce RM, Sutherland LL, Yu JS, Decker JM, Shaw GM, Montefiori DC, Korber BT, Hahn BH, et al. Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type 1 group m consensus envelope glycoprotein. Journal of Virology. 79: 1154-63. PMID 15613343 DOI: 10.1128/JVI.79.2.1154-1163.2005  0.56
2004 Gao F, Korber BT, Weaver EA, Liao HX, Hahn BH, Haynes BF. Centralized immunogens as a vaccine strategy to overcome HIV-1 diversity Expert Review of Vaccines. 3. PMID 15285714 DOI: 10.1586/14760584.3.4.S161  0.56
2004 Phadke AP, Choi IS, Li Z, Weaver E, Collisson EW. The role of inducer cells in mediating in vitro suppression of feline immunodeficiency virus replication. Virology. 320: 63-74. PMID 15003863 DOI: 10.1016/j.virol.2003.11.016  0.56
2004 Weaver EA, Collisson EW, Slater M, Zhu G. Phylogenetic analyses of Texas isolates indicate an evolving subtype of the clade B feline immunodeficiency viruses. Journal of Virology. 78: 2158-63. PMID 14747582 DOI: 10.1128/JVI.78.4.2158-2163.2004  0.56
2001 Whiteley M, Ott JR, Weaver EA, McLean RJ. Effects of community composition and growth rate on aquifer biofilm bacteria and their susceptibility to betadine disinfection. Environmental Microbiology. 3: 43-52. PMID 11225722 DOI: 10.1046/j.1462-2920.2001.00158.x  0.56
2000 Kovar DR, Staiger CJ, Weaver EA, McCurdy DW. AtFim1 is an actin filament crosslinking protein from Arabidopsis thaliana Plant Journal. 24: 625-636. PMID 11123801 DOI: 10.1046/j.1365-313X.2000.00907.x  0.56
Show low-probability matches.